A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain

Trial Profile

A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Feb 2016

At a glance

  • Drugs Bevenopran (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Sponsors Adolor Corporation
  • Most Recent Events

    • 22 May 2012 Results presented at the Digestive Disease Week 2012.
    • 19 May 2012 Results presented at the 31st Annual Scientific Meeting of the American Pain Society.
    • 14 May 2012 Results will be presented at the Annual Scientific Meeting of the American Pain Society (APS) in May 2012.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top